Condition: Bipolar 1 Disorder · Sponsor: Rapport Therapeutics Inc.
This is a clinical research study for an investigational drug called RAP-219 in participants with bipolar I disorder. This study is being conducted to determine if RAP-219 is safe and effective in participants experiencing mania associated with bipolar I disorder.
This description comes directly from the study's public registry record.
Dawn F Fenton · (857) 323-9048 · dfenton@rapportrx.com
Always discuss trial participation with your own doctor first.
| Pillar Clinical Research - Little Rock | Little Rock, Arkansas, United States | Recruiting |
| Woodland International Research Group | Little Rock, Arkansas, United States | Withdrawn |
| Woodland Research Northwest | Rogers, Arkansas, United States | Recruiting |
| Inland Psychiatric Medical Group - Chino | Chino, California, United States | Active Not Recruiting |
| Synergy Clinical Research Center - San Diego | Lemon Grove, California, United States | Recruiting |
| Collaborative Neuroscience Research - Los Alamitos | Los Alamitos, California, United States | Recruiting |
| NRC Research Institute - Orange | Orange, California, United States | Recruiting |
| CNRI - San Diego, LLC | San Diego, California, United States | Withdrawn |
| NeuroBehavioral Hospitals of the Palm Beaches - South | Boynton Beach, Florida, United States | Recruiting |
| United Research Institute | Hialeah, Florida, United States | Recruiting |
| CenExel - Hollywood | Hollywood, Florida, United States | Recruiting |
| Segal Trials - Miami Lakes Medical Research Early Phase, Inpatient & Outpatient Site | Miami Lakes, Florida, United States | Recruiting |
+ 10 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07046494